Cleo Diagnostics Ltd - Asset Resilience Ratio

Latest as of December 2025: 94.64%

Cleo Diagnostics Ltd (COV) has an Asset Resilience Ratio of 94.64% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital to net assets of Cleo Diagnostics Ltd to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$9.43 Million

≈ $6.67 Million USD Cash + Short-term Investments

Total Assets

AU$9.96 Million

≈ $7.05 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2024–2025)

This chart shows how Cleo Diagnostics Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Cleo Diagnostics Ltd total assets.

Liquid Assets Composition Over Time

This chart breaks down Cleo Diagnostics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Cleo Diagnostics Ltd (COV) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$9.43 Million	94.64%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$9.43 Million	94.64%

Asset Resilience Insights

Very High Liquidity: Cleo Diagnostics Ltd maintains exceptional liquid asset reserves at 94.64% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Cleo Diagnostics Ltd Industry Peers by Asset Resilience Ratio

Compare Cleo Diagnostics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Eurobio Scientific SA PA:ALERS	Medical Devices	10.52%
Profound Medical Corp TO:PRN	Medical Devices	67.66%
EBR Systems Inc AU:EBR	Medical Devices	54.70%
Epitomee Medical Ltd TA:EPIT	Medical Devices	0.24%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for Cleo Diagnostics Ltd (2024–2025)

The table below shows the annual Asset Resilience Ratio data for Cleo Diagnostics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	82.37%	AU$5.71 Million ≈ $4.04 Million	AU$6.94 Million ≈ $4.91 Million	+61.62pp
2024-06-30	20.75%	AU$2.05 Million ≈ $1.45 Million	AU$9.88 Million ≈ $6.99 Million	--

pp = percentage points

About Cleo Diagnostics Ltd

AU:COV Australia Medical Devices

Market Cap

$31.96 Million

AU$45.16 Million AUD

Market Cap Rank

#23635 Global

#909 in Australia

Share Price

AU$0.33

Change (1 day)

+10.00%

52-Week Range

AU$0.30 - AU$0.87

All Time High

AU$0.87